143 related articles for article (PubMed ID: 30779917)
1. Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway.
Yanchun M; Yi W; Lu W; Yu Q; Jian Y; Pengzhou K; Ting Y; Hongyi L; Fang W; Xiaolong C; Yongping C
Eur J Pharmacol; 2019 May; 851():43-51. PubMed ID: 30779917
[TBL] [Abstract][Full Text] [Related]
2. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
3. Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1/mitogen-activated protein kinases cascade in osteosarcoma cells.
Qin W; Li S; Miao Y; Shi Q; Wang Y; Li J; Chen Z; Wang J; Ling C
Neoplasma; 2018; 65(1):21-33. PubMed ID: 29322785
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
5. Deoxypodophyllotoxin, a Lignan from
Kwak AW; Lee MH; Yoon G; Cho SS; Choi JS; Chae JI; Shim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961992
[TBL] [Abstract][Full Text] [Related]
6. Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway.
Fan W; Sun L; Zhou JQ; Zhang C; Qin S; Tang Y; Liu Y; Lin SS; Yuan ST
Chin J Nat Med; 2015 Jun; 13(6):428-37. PubMed ID: 26073339
[TBL] [Abstract][Full Text] [Related]
7. Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis.
Tan BJ; Chiu GN
Int J Oncol; 2013 May; 42(5):1605-12. PubMed ID: 23467622
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of triptolide on glioblastoma multiforme in vitro.
Lin J; Chen L; Lin Z; Zhao M
J Int Med Res; 2007; 35(4):490-6. PubMed ID: 17697526
[TBL] [Abstract][Full Text] [Related]
9. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells.
Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
Biomed Pharmacother; 2017 Feb; 86():677-685. PubMed ID: 28038429
[TBL] [Abstract][Full Text] [Related]
10. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
Wan CK; Wang C; Cheung HY; Yang M; Fong WF
Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway.
Yang Y; Ye Y; Qiu Q; Xiao Y; Huang M; Shi M; Liang L; Yang X; Xu H
Int Immunopharmacol; 2016 Dec; 41():8-16. PubMed ID: 27816728
[TBL] [Abstract][Full Text] [Related]
12. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin.
Zhao H; Yang Z; Wang X; Zhang X; Wang M; Wang Y; Mei Q; Wang Z
Exp Mol Med; 2012 Nov; 44(11):633-41. PubMed ID: 22902510
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits proliferation and invasion of malignant glioma cells.
Zhang H; Zhu W; Su X; Wu S; Lin Y; Li J; Wang Y; Chen J; Zhou Y; Qiu P; Yan G; Zhao S; Hu J; Zhang J
J Neurooncol; 2012 Aug; 109(1):53-62. PubMed ID: 22562416
[TBL] [Abstract][Full Text] [Related]
16. WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.
Chai DM; Qin YZ; Wu SW; Ma L; Tan YY; Yong X; Wang XL; Wang ZP; Tao YS
J Exp Clin Cancer Res; 2019 Feb; 38(1):102. PubMed ID: 30808397
[TBL] [Abstract][Full Text] [Related]
17. [Effects of triptolide on cell proliferation and regulation of Ras-MAPKs pathway in synoviocytes induced by tumor necrosis factor].
Wang J; Lian J; Kong X; Lin N
Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(7):888-91. PubMed ID: 20575393
[TBL] [Abstract][Full Text] [Related]
18. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.
Miyata Y; Sato T; Ito A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1081-6. PubMed ID: 16176806
[TBL] [Abstract][Full Text] [Related]
19. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
20. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
